A patent for non-invasive prenatal diagnosis by detecting fetal DNA in maternal serum or plasma was held valid (save for one claim lacking fair basis) and infringed by the Harmony Test, with the Court construing 'prenatal diagnosis' broadly to encompass screening, rejecting a requirement that fetal origin be 'known in advance', and holding that test results generated overseas from Australian samples and transmitted back to Australia constitute an importable 'product' of the patented method.
The full text is available to signed-in members, including the 12 later cases that cite this judgment.
1 of the 12 citing cases carry a classified treatment. How each court treated it is available to signed-in members.